We came across a bullish thesis on Baxter International Inc. on DeepValue Capital’s Substack. In this article, we will ...

While Baxter International has lagged the broader market over the past year, Wall Street analysts remain cautiously ...

Stifel downgraded Baxter International to ‘Hold’ from ‘Buy’ and slashed the price target to $25 from $36. The analysts ...

Baxter International slashed its 2025 profit forecast and posted disappointing quarterly earnings on Thursday, as lingering ...

Deerfield-based Baxter International is still feeling battered by Hurricane Helene and problems with its Novum infusion pumps ...

Baxter International (NYSE:BAX) stock drops after the company's Q2 results miss consensus and Q3 projection fails to meet ...

Baxter International cut its 2025 profit forecast on Thursday, while quarterly earnings missed analysts' estimates due to the ...

Stifel lowered PT to $25 from $36, and downgraded rating from "Buy". Stifel analysts said that while Baxter has made positive ...

Baxter International has voluntarily paused shipments and planned installations of its Novum infusion pump. In April, the FDA reported an underinfusion risk with the company’s Novum IQ large-volume ...

Baxter International Inc. BAX is scheduled to release second-quarter 2025 results on July 31, before the opening bell. In the ...

Baxter International Inc. ( NYSE: BAX) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Clare Trachtman - Vice President of Investor Relations David Brent Shafer - Chair & Interim CEO Heather ...

Baxter International on Monday named Andrew Hider, chief executive of Canadian automation solutions firm ATS Corp., its new ...